{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:23:15Z","timestamp":1789154595019,"version":"build-2803163510"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T00:00:00Z","timestamp":1630540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["5R24OD028748-02"],"award-info":[{"award-number":["5R24OD028748-02"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mamm Genome"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00335-021-09907-y","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T18:23:57Z","timestamp":1630693437000},"page":"230-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Swine models for translational oncological research: an evolving landscape and regulatory considerations"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3791-612X","authenticated-orcid":false,"given":"Adeline N.","family":"Boettcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7293-8642","authenticated-orcid":false,"given":"Kyle M.","family":"Schachtschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6580-8364","authenticated-orcid":false,"given":"Lawrence B.","family":"Schook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4229-5316","authenticated-orcid":false,"given":"Christopher K.","family":"Tuggle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"key":"9907_CR1","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/sj.onc.1209892","volume":"26","author":"SJ Adam","year":"2007","unstructured":"Adam SJ, Rund LA, Kuzmuk KN et al (2007) Genetic induction of tumorigenesis in Swine. Oncogene 26:1038\u20131045. https:\/\/doi.org\/10.1038\/sj.onc.1209892","journal-title":"Oncogene"},{"key":"9907_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12935-019-0954-3","volume":"19","author":"AR Andrews","year":"2019","unstructured":"Andrews AR, Wang Z, Wilkinson RA et al (2019) Development of transplantable B-cell lymphomas in the MHC-defined miniature swine model. Cancer Cell Int 19:236. https:\/\/doi.org\/10.1186\/s12935-019-0954-3","journal-title":"Cancer Cell Int"},{"key":"9907_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/biores.2012.9902","volume":"1","author":"MT Basel","year":"2012","unstructured":"Basel MT, Balivada S, Beck AP et al (2012) Human xenografts are not rejected in a naturally occurring immunodeficient porcine line: a human tumor model in pigs. Biores Open Access 1:63\u201368. https:\/\/doi.org\/10.1089\/biores.2012.9902","journal-title":"Biores Open Access"},{"key":"9907_CR4","doi-asserted-by":"publisher","first-page":"e0239391","DOI":"10.1371\/journal.pone.0239391","volume":"15","author":"FE Boas","year":"2020","unstructured":"Boas FE, Nurili F, Bendet A et al (2020) Induction and characterization of pancreatic cancer in a transgenic pig model. PLoS One 15:e0239391. https:\/\/doi.org\/10.1371\/journal.pone.0239391","journal-title":"PLoS One"},{"key":"9907_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fimmu.2020.00510","volume":"11","author":"AN Boettcher","year":"2020","unstructured":"Boettcher AN, Cino-Ozuna AG, Solanki Y et al (2020a) CD3\u03b5(+) cells in pigs with severe combined immunodeficiency due to defects in ARTEMIS. Front Immunol 11:510. https:\/\/doi.org\/10.3389\/fimmu.2020.00510","journal-title":"Front Immunol"},{"key":"9907_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fonc.2019.00009","volume":"9","author":"AN Boettcher","year":"2019","unstructured":"Boettcher AN, Kiupel M, Adur MK et al (2019) Human ovarian cancer tumor formation in Severe Combined Immunodeficient (SCID) Pigs. Front Oncol 9:9","journal-title":"Front Oncol"},{"key":"9907_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2020.00100","volume":"11","author":"AN Boettcher","year":"2020","unstructured":"Boettcher AN, Li Y, Ahrens AP et al (2020b) Novel Engraftment and T cell differentiation of human hematopoietic cells in ART (-\/-) IL2RG (-\/Y) SCID Pigs. Front Immunol 11:100. https:\/\/doi.org\/10.3389\/fimmu.2020.00100","journal-title":"Front Immunol"},{"key":"9907_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3389\/fonc.2018.00559","volume":"8","author":"AN Boettcher","year":"2018","unstructured":"Boettcher AN, Loving CL, Cunnick JE, Tuggle CK (2018) Development of Severe Combined Immunodeficient (SCID) pig models for translational cancer modeling: future insights on how humanized SCID pigs can improve preclinical cancer research. Front Oncol 8:559","journal-title":"Front Oncol"},{"key":"9907_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tox.2016.11.014","volume":"375","author":"V Burkina","year":"2017","unstructured":"Burkina V, Rasmussen MK, Pilipenko N, Zamaratskaia G (2017) Comparison of xenobiotic-metabolising human, porcine, rodent, and piscine cytochrome P450. Toxicology 375:10\u201327. https:\/\/doi.org\/10.1016\/j.tox.2016.11.014","journal-title":"Toxicology"},{"key":"9907_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.trecan.2018.05.004","volume":"4","author":"I Chatzistamou","year":"2018","unstructured":"Chatzistamou I, Farmaki E, Kaza V, Kiaris H (2018) The value of outbred rodent models in cancer research. Trends in Cancer 4:468\u2013471. https:\/\/doi.org\/10.1016\/j.trecan.2018.05.004","journal-title":"Trends in Cancer"},{"key":"9907_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/cts.12635","volume":"12","author":"D Chiodin","year":"2019","unstructured":"Chiodin D, Cox EM, Edmund AV et al (2019) Regulatory affairs 101: introduction to investigational new drug applications and clinical trial applications. Clin Transl Sci 12:334\u2013342. https:\/\/doi.org\/10.1111\/cts.12635","journal-title":"Clin Transl Sci"},{"key":"9907_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jso.24922","volume":"117","author":"WJ Choi","year":"2018","unstructured":"Choi WJ, Moon J-H, Min JS et al (2018) Real-time detection system for tumor localization during minimally invasive surgery for gastric and colon cancer removal: In vivo feasibility study in a swine model. J Surg Oncol 117:699\u2013706. https:\/\/doi.org\/10.1002\/jso.24922","journal-title":"J Surg Oncol"},{"key":"9907_CR13","doi-asserted-by":"publisher","unstructured":"Choi Y-J, Kim E, Reza AMMT, et al (2017) Recombination activating gene-2(null) severe combined immunodeficient pigs and mice engraft human induced pluripotent stem cells differently. Oncotarget 8:69398\u201369407. https:\/\/doi.org\/10.18632\/oncotarget.20626","DOI":"10.18632\/oncotarget.20626"},{"key":"9907_CR14","doi-asserted-by":"publisher","unstructured":"Cizkova J, Sinkorova Z, Strnadova K, et al (2019) The role of \u03b1\u03b2 T-cells in spontaneous regression of melanoma tumors in swine. Dev Comp Immunol 92:60\u201368. https:\/\/doi.org\/10.1016\/j.dci.2018.10.001","DOI":"10.1016\/j.dci.2018.10.001"},{"key":"9907_CR15","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.4049\/jimmunol.1300097","volume":"190","author":"J Conlon","year":"2013","unstructured":"Conlon J, Burdette DL, Sharma S et al (2013) Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J Immunol 190:5216\u20135225. https:\/\/doi.org\/10.4049\/jimmunol.1300097","journal-title":"J Immunol"},{"key":"9907_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/1471-2164-14-332","volume":"14","author":"HD Dawson","year":"2013","unstructured":"Dawson HD, Loveland JE, Pascal G et al (2013) Structural and functional annotation of the porcine immunome. BMC Genomics 14:332. https:\/\/doi.org\/10.1186\/1471-2164-14-332","journal-title":"BMC Genomics"},{"key":"9907_CR17","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/MPA.0000000000001642","volume":"49","author":"R De\u017eman","year":"2020","unstructured":"De\u017eman R, \u010cema\u017ear M, Ser\u0161a G et al (2020) Safety and feasibility of electrochemotherapy of the pancreas in a porcine model. Pancreas 49:1168\u20131173. https:\/\/doi.org\/10.1097\/MPA.0000000000001642","journal-title":"Pancreas"},{"key":"9907_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fgene.2015.00269","volume":"6","author":"H Donninger","year":"2015","unstructured":"Donninger H, Hobbing K, Schmidt ML et al (2015) A porcine model system of BRCA1 driven breast cancer. Front Genet 6:269. https:\/\/doi.org\/10.3389\/fgene.2015.00269","journal-title":"Front Genet"},{"key":"9907_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.vetimm.2009.12.005","volume":"135","author":"R Duran-Struuck","year":"2010","unstructured":"Duran-Struuck R, Cho PS, Teague AGS et al (2010) Myelogenous leukemia in adult inbred MHC-defined miniature swine: a model for human myeloid leukemias. Vet Immunol Immunopathol 135:243\u2013256. https:\/\/doi.org\/10.1016\/j.vetimm.2009.12.005","journal-title":"Vet Immunol Immunopathol"},{"key":"9907_CR20","unstructured":"FDA (2018) Immunomagnetic Circulating Cancer Cell Selection and Enumeration System - Class II Special Controls Guidance Document for Industry and FDA Staff"},{"key":"9907_CR21","unstructured":"FDA (2017) Medical Devices; Gastroenterology-Urology Devices; Classification of the High Intensity Ultrasound System for Prostate Tissue Ablation"},{"key":"9907_CR22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1053\/j.gastro.2012.07.110","volume":"143","author":"T Flisikowska","year":"2012","unstructured":"Flisikowska T, Merkl C, Landmann M et al (2012) A porcine model of familial adenomatous polyposis. Gastroenterology 143:1173-1175.e7. https:\/\/doi.org\/10.1053\/j.gastro.2012.07.110","journal-title":"Gastroenterology"},{"key":"9907_CR23","doi-asserted-by":"publisher","first-page":"6613","DOI":"10.1038\/s41598-017-06741-8","volume":"7","author":"T Flisikowska","year":"2017","unstructured":"Flisikowska T, Stachowiak M, Xu H et al (2017) Porcine familial adenomatous polyposis model enables systematic analysis of early events in adenoma progression. Sci Rep 7:6613. https:\/\/doi.org\/10.1038\/s41598-017-06741-8","journal-title":"Sci Rep"},{"key":"9907_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.conctc.2018.08.001","volume":"11","author":"DB Fogel","year":"2018","unstructured":"Fogel DB (2018) Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun 11:156\u2013164. https:\/\/doi.org\/10.1016\/j.conctc.2018.08.001","journal-title":"Contemp Clin Trials Commun"},{"key":"9907_CR25","doi-asserted-by":"publisher","unstructured":"Gaba RC, Elkhadragy L, Boas FE, et al (2020) Development and comprehensive characterization of porcine hepatocellular carcinoma for translational liver cancer investigation. Oncotarget 11:2686\u20132701. https:\/\/doi.org\/10.18632\/oncotarget.27647","DOI":"10.18632\/oncotarget.27647"},{"key":"9907_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-animal-022114-110911","volume":"4","author":"HL Gardner","year":"2016","unstructured":"Gardner HL, Fenger JM, London CA (2016) Dogs as a model for cancer. Annu Rev Anim Biosci 4:199\u2013222. https:\/\/doi.org\/10.1146\/annurev-animal-022114-110911","journal-title":"Annu Rev Anim Biosci"},{"key":"9907_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nature11622","volume":"491","author":"MAM Groenen","year":"2012","unstructured":"Groenen MAM, Archibald AL, Uenishi H et al (2012) Analyses of pig genomes provide insight into porcine demography and evolution. Nature 491:393\u2013398. https:\/\/doi.org\/10.1038\/nature11622","journal-title":"Nature"},{"key":"9907_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1538\/expanim.17-0095","volume":"67","author":"H Hara","year":"2018","unstructured":"Hara H, Shibata H, Nakano K et al (2018) Production and rearing of germ-free X-SCID pigs. Exp Anim 67:139\u2013146. https:\/\/doi.org\/10.1538\/expanim.17-0095","journal-title":"Exp Anim"},{"key":"9907_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1517\/17425255.2013.739607","volume":"9","author":"KL Helke","year":"2013","unstructured":"Helke KL, Swindle MM (2013) Animal models of toxicology testing: the role of pigs. Expert Opin Drug Metab Toxicol 9:127\u2013139. https:\/\/doi.org\/10.1517\/17425255.2013.739607","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"9907_CR30","doi-asserted-by":"publisher","first-page":"7584","DOI":"10.1038\/s41598-021-87228-5","volume":"11","author":"A Hendricks-Wenger","year":"2021","unstructured":"Hendricks-Wenger A, Aycock KN, Nagai-Singer MA et al (2021) Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation. Sci Rep 11:7584. https:\/\/doi.org\/10.1038\/s41598-021-87228-5","journal-title":"Sci Rep"},{"key":"9907_CR31","unstructured":"Hor\u00e1k V, Fort\u00fdn K, Hruban V, Klaudy J (1999) Hereditary melanoblastoma in miniature pigs and its successful therapy by devitalization technique. Cell Mol Biol (Noisy-le-grand) 45:1119\u20131129"},{"key":"9907_CR32","doi-asserted-by":"publisher","first-page":"286","DOI":"10.4103\/jcrt.JCRT_986_17","volume":"15","author":"G Huang","year":"2019","unstructured":"Huang G, Ye X, Yang X et al (2019) Experimental study in vivo ablation of swine pancreas using high-intensity focused ultrasound. J Cancer Res Ther 15:286\u2013290. https:\/\/doi.org\/10.4103\/jcrt.JCRT_986_17","journal-title":"J Cancer Res Ther"},{"key":"9907_CR33","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.4049\/jimmunol.1400915","volume":"193","author":"J Huang","year":"2014","unstructured":"Huang J, Guo X, Fan N et al (2014) RAG1\/2 knockout pigs with severe combined immunodeficiency. J Immunol 193:1496\u20131503. https:\/\/doi.org\/10.4049\/jimmunol.1400915","journal-title":"J Immunol"},{"key":"9907_CR34","doi-asserted-by":"publisher","first-page":"e113833","DOI":"10.1371\/journal.pone.0113833","volume":"9","author":"T Ito","year":"2014","unstructured":"Ito T, Sendai Y, Yamazaki S et al (2014) Generation of recombination activating gene-1-deficient neonatal piglets: a model of T and B cell deficient severe combined immune deficiency. PLoS One 9:e113833. https:\/\/doi.org\/10.1371\/journal.pone.0113833","journal-title":"PLoS One"},{"key":"9907_CR35","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/jama.2013.286274","volume":"311","author":"J Jin","year":"2014","unstructured":"Jin J (2014) FDA authorization of medical devices. JAMA 311:435. https:\/\/doi.org\/10.1001\/jama.2013.286274","journal-title":"JAMA"},{"key":"9907_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12958-016-0206-5","volume":"14","author":"J-T Kang","year":"2016","unstructured":"Kang J-T, Cho B, Ryu J et al (2016) Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs. Reprod Biol Endocrinol 14:74. https:\/\/doi.org\/10.1186\/s12958-016-0206-5","journal-title":"Reprod Biol Endocrinol"},{"key":"9907_CR37","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.4049\/jimmunol.1102649","volume":"188","author":"R Kapetanovic","year":"2012","unstructured":"Kapetanovic R, Fairbairn L, Beraldi D et al (2012) Pig bone marrow-derived macrophages resemble human macrophages in their response to bacterial lipopolysaccharide. J Immunol 188:3382\u20133394. https:\/\/doi.org\/10.4049\/jimmunol.1102649","journal-title":"J Immunol"},{"key":"9907_CR38","doi-asserted-by":"publisher","unstructured":"K\u00e4ser T (2021) Swine as biomedical animal model for T-cell research\u2014Success and potential for transmittable and non-transmittable human diseases. Mol Immunol 135:95\u2013115. https:\/\/doi.org\/10.1016\/j.molimm.2021.04.004","DOI":"10.1016\/j.molimm.2021.04.004"},{"key":"9907_CR39","doi-asserted-by":"publisher","unstructured":"Khoshnevis M, Carozzo C, Bonnefont-Rebeix C, et al (2017) Development of induced glioblastoma by implantation of a human xenograft in Yucatan minipig as a large animal model. J Neurosci Methods 282:61\u201368. https:\/\/doi.org\/10.1016\/j.jneumeth.2017.03.007","DOI":"10.1016\/j.jneumeth.2017.03.007"},{"key":"9907_CR40","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.3390\/s19122815","volume":"19","author":"K Kratkiewicz","year":"2019","unstructured":"Kratkiewicz K, Manwar R, Rajabi-Estarabadi A et al (2019) Photoacoustic\/ultrasound\/optical coherence tomography evaluation of melanoma lesion and healthy skin in a swine model. Sensors (basel) 19:2815. https:\/\/doi.org\/10.3390\/s19122815","journal-title":"Sensors (basel)"},{"key":"9907_CR41","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1038\/s41598-019-44171-w","volume":"9","author":"T Kurihara","year":"2019","unstructured":"Kurihara T, Matsuda S, Nakamura Y et al (2019) Establishment of a model of sentinel lymph node metastasis using immunodeficient swine. Sci Rep 9:7923. https:\/\/doi.org\/10.1038\/s41598-019-44171-w","journal-title":"Sci Rep"},{"key":"9907_CR42","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1200\/JCO.2011.35.0660","volume":"29","author":"PNJ Lara","year":"2011","unstructured":"Lara PNJ, Douillard J-Y, Nakagawa K et al (2011) Randomized phase III placebo-controlled trial of carboplatin and paclitaxel with or without the vascular disrupting agent vadimezan (ASA404) in advanced non-small-cell lung cancer. J Clin Oncol off J Am Soc Clin Oncol 29:2965\u20132971. https:\/\/doi.org\/10.1200\/JCO.2011.35.0660","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"9907_CR43","doi-asserted-by":"publisher","first-page":"20140233","DOI":"10.1098\/rstb.2014.0233","volume":"370","author":"J Lawrence","year":"2015","unstructured":"Lawrence J, Cameron D, Argyle D (2015) Species differences in tumour responses to cancer chemotherapy. Philos Trans R Soc Lond B Biol Sci 370:20140233. https:\/\/doi.org\/10.1098\/rstb.2014.0233","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"9907_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11060-017-2388-x","volume":"132","author":"JC League-Pascual","year":"2017","unstructured":"League-Pascual JC, Lester-McCully CM, Shandilya S et al (2017) Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model. J Neurooncol 132:401\u2013407. https:\/\/doi.org\/10.1007\/s11060-017-2388-x","journal-title":"J Neurooncol"},{"key":"9907_CR45","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1073\/pnas.1406376111","volume":"111","author":"K Lee","year":"2014","unstructured":"Lee K, Kwon D-N, Ezashi T et al (2014) Engraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency. Proc Natl Acad Sci U S A 111:7260\u20137265. https:\/\/doi.org\/10.1073\/pnas.1406376111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9907_CR46","doi-asserted-by":"publisher","first-page":"25222","DOI":"10.1038\/srep25222","volume":"6","author":"S Lei","year":"2016","unstructured":"Lei S, Ryu J, Wen K et al (2016) Increased and prolonged human norovirus infection in RAG2\/IL2RG deficient gnotobiotic pigs with severe combined immunodeficiency. Sci Rep 6:25222. https:\/\/doi.org\/10.1038\/srep25222","journal-title":"Sci Rep"},{"key":"9907_CR47","doi-asserted-by":"publisher","first-page":"e43323","DOI":"10.1371\/journal.pone.0043323","volume":"7","author":"S Leuchs","year":"2012","unstructured":"Leuchs S, Saalfrank A, Merkl C et al (2012) Inactivation and inducible oncogenic mutation of p53 in gene targeted pigs. PLoS One 7:e43323","journal-title":"PLoS One"},{"key":"9907_CR48","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s11248-015-9866-8","volume":"24","author":"S Li","year":"2015","unstructured":"Li S, Edlinger M, Saalfrank A et al (2015) Viable pigs with a conditionally-activated oncogenic KRAS mutation. Transgenic Res 24:509\u2013517. https:\/\/doi.org\/10.1007\/s11248-015-9866-8","journal-title":"Transgenic Res"},{"key":"9907_CR49","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1148\/radiol.2019181652","volume":"291","author":"AWP Maxwell","year":"2019","unstructured":"Maxwell AWP, Park WKC, Baird GL et al (2019) Effects of a thermal accelerant gel on microwave ablation zone volumes in lung: a porcine study. Radiology 291:504\u2013510. https:\/\/doi.org\/10.1148\/radiol.2019181652","journal-title":"Radiology"},{"key":"9907_CR50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tim.2011.11.002","volume":"20","author":"F Meurens","year":"2012","unstructured":"Meurens F, Summerfield A, Nauwynck H et al (2012) The pig: a model for human infectious diseases. Trends Microbiol 20:50\u201357. https:\/\/doi.org\/10.1016\/j.tim.2011.11.002","journal-title":"Trends Microbiol"},{"key":"9907_CR51","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fphar.2018.00470","volume":"9","author":"J Millecam","year":"2018","unstructured":"Millecam J, De Clerck L, Govaert E et al (2018) The ontogeny of cytochrome p450 enzyme activity and protein abundance in conventional pigs in support of preclinical pediatric drug research. Front Pharmacol 9:470","journal-title":"Front Pharmacol"},{"key":"9907_CR52","doi-asserted-by":"publisher","first-page":"e0248352","DOI":"10.1371\/journal.pone.0248352","volume":"16","author":"K Mishima","year":"2021","unstructured":"Mishima K, Itano O, Matsuda S et al (2021) Development of human hepatocellular carcinoma in X-linked severe combined immunodeficient pigs: an orthotopic xenograft model. PLoS One 16:e0248352. https:\/\/doi.org\/10.1371\/journal.pone.0248352","journal-title":"PLoS One"},{"key":"9907_CR53","doi-asserted-by":"publisher","first-page":"10695","DOI":"10.1021\/acsnano.5b05974","volume":"9","author":"SK Misra","year":"2015","unstructured":"Misra SK, Ghoshal G, Gartia MR et al (2015) Trimodal therapy: combining hyperthermia with repurposed bexarotene and ultrasound for treating liver cancer. ACS Nano 9:10695\u201310718. https:\/\/doi.org\/10.1021\/acsnano.5b05974","journal-title":"ACS Nano"},{"key":"9907_CR54","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ejps.2013.08.018","volume":"57","author":"H Musther","year":"2014","unstructured":"Musther H, Olivares-Morales A, Hatley OJD et al (2014) Animal versus human oral drug bioavailability: do they correlate? Eur J Pharm Sci off J Eur Fed Pharm Sci 57:280\u2013291. https:\/\/doi.org\/10.1016\/j.ejps.2013.08.018","journal-title":"Eur J Pharm Sci off J Eur Fed Pharm Sci"},{"key":"9907_CR55","doi-asserted-by":"publisher","first-page":"7186","DOI":"10.1021\/acs.jmedchem.7b00966","volume":"60","author":"MT Nedelcovych","year":"2017","unstructured":"Nedelcovych MT, Tenora L, Kim B-H et al (2017) N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders. J Med Chem 60:7186\u20137198. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b00966","journal-title":"J Med Chem"},{"key":"9907_CR56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10549-017-4548-2","volume":"167","author":"F Nguyen","year":"2018","unstructured":"Nguyen F, Pe\u00f1a L, Ibisch C et al (2018) Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors. Breast Cancer Res Treat 167:635\u2013648. https:\/\/doi.org\/10.1007\/s10549-017-4548-2","journal-title":"Breast Cancer Res Treat"},{"key":"9907_CR57","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jvir.2020.09.011","volume":"32","author":"F Nurili","year":"2021","unstructured":"Nurili F, Monette S, Michel AO et al (2021) Transarterial embolization of liver cancer in a transgenic pig model. J Vasc Interv Radiol 32:510-517.e3. https:\/\/doi.org\/10.1016\/j.jvir.2020.09.011","journal-title":"J Vasc Interv Radiol"},{"key":"9907_CR58","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/cells8080889","volume":"8","author":"S Okada","year":"2019","unstructured":"Okada S, Vaeteewoottacharn K, Kariya R (2019) Application of highly immunocompromised mice for the establishment of Patient-Derived Xenograft (PDX) models. Cells 8:889. https:\/\/doi.org\/10.3390\/cells8080889","journal-title":"Cells"},{"key":"9907_CR59","doi-asserted-by":"publisher","unstructured":"Ortega-Palacios R, Trujillo-Romero CJ, Cepeda Rubio MFJ, et al (2018) Feasibility of using a novel 2.45\u2009GHz double short distance slot coaxial antenna for minimally invasive cancer breast microwave ablation therapy: computational model, phantom, and in vivo swine experimentation. J Healthc Eng 2018:5806753. https:\/\/doi.org\/10.1155\/2018\/5806753","DOI":"10.1155\/2018\/5806753"},{"key":"9907_CR60","first-page":"707","volume":"96","author":"RW Oxenhandler","year":"1979","unstructured":"Oxenhandler RW, Adelstein EH, Haigh JP et al (1979) Malignant melanoma in the Sinclair miniature swine: an autopsy study of 60 cases. Am J Pathol 96:707\u2013720","journal-title":"Am J Pathol"},{"key":"9907_CR61","doi-asserted-by":"publisher","first-page":"e0129954","DOI":"10.1371\/journal.pone.0129954","volume":"10","author":"M Paoloni","year":"2015","unstructured":"Paoloni M, Mazcko C, Selting K et al (2015) Defining the pharmacodynamic profile and therapeutic index of NHS-IL12 immunocytokine in dogs with malignant melanoma. PLoS One 10:e0129954\u2013e0129954. https:\/\/doi.org\/10.1371\/journal.pone.0129954","journal-title":"PLoS One"},{"key":"9907_CR62","doi-asserted-by":"publisher","first-page":"160","DOI":"10.5625\/lar.2018.34.4.160","volume":"34","author":"MK Park","year":"2018","unstructured":"Park MK, Lee CH, Lee H (2018) Mouse models of breast cancer in preclinical research. Lab Anim Res 34:160\u2013165. https:\/\/doi.org\/10.5625\/lar.2018.34.4.160","journal-title":"Lab Anim Res"},{"key":"9907_CR63","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/0023677217750691","volume":"52","author":"EJ Powell","year":"2018","unstructured":"Powell EJ, Charley S, Boettcher AN et al (2018) Creating effective biocontainment facilities and maintenance protocols for raising specific pathogen-free, severe combined immunodeficient (SCID) pigs. Lab Anim 52:402\u2013412. https:\/\/doi.org\/10.1177\/0023677217750691","journal-title":"Lab Anim"},{"key":"9907_CR64","doi-asserted-by":"publisher","first-page":"12548","DOI":"10.1038\/s41598-018-30916-6","volume":"8","author":"DR Principe","year":"2018","unstructured":"Principe DR, Overgaard NH, Park AJ et al (2018) KRAS(G12D) and TP53(R167H) cooperate to induce pancreatic ductal adenocarcinoma in Sus scrofa pigs. Sci Rep 8:12548. https:\/\/doi.org\/10.1038\/s41598-018-30916-6","journal-title":"Sci Rep"},{"key":"9907_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/genes10070501","author":"A Prouteau","year":"2019","unstructured":"Prouteau A, Andr\u00e9 C (2019) Canine melanomas as models for human melanomas: clinical, histological, and genetic comparison. Genes (basel). https:\/\/doi.org\/10.3390\/genes10070501","journal-title":"Genes (basel)"},{"key":"9907_CR66","doi-asserted-by":"publisher","first-page":"8621","DOI":"10.1021\/acs.jmedchem.6b01069","volume":"59","author":"R Rais","year":"2016","unstructured":"Rais R, Jan\u010da\u0159\u00edk A, Tenora L et al (2016) Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with enhanced CSF delivery in monkeys: a potential treatment for glioblastoma. J Med Chem 59:8621\u20138633. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01069","journal-title":"J Med Chem"},{"key":"9907_CR67","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ijrobp.2018.02.024","volume":"101","author":"AD Rao","year":"2018","unstructured":"Rao AD, Shin EJ, Beck SE et al (2018) Demonstration of safety and feasibility of hydrogel marking of the pancreas-duodenum interface for Image Guided Radiation Therapy (IGRT) in a porcine model: implications in IGRT for pancreatic cancer patients. Int J Radiat Oncol Biol Phys 101:640\u2013645. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.02.024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"9907_CR68","doi-asserted-by":"publisher","first-page":"e12863","DOI":"10.1111\/cpr.12863","volume":"53","author":"J Ren","year":"2020","unstructured":"Ren J, Yu D, Fu R et al (2020) IL2RG-deficient minipigs generated via CRISPR\/Cas9 technology support the growth of human melanoma-derived tumours. Cell Prolif 53:e12863. https:\/\/doi.org\/10.1111\/cpr.12863","journal-title":"Cell Prolif"},{"key":"9907_CR69","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1089\/jir.2007.0992","volume":"28","author":"ZJ Roberts","year":"2008","unstructured":"Roberts ZJ, Ching L-M, Vogel SN (2008) IFN-beta-dependent inhibition of tumor growth by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA). J Interf Cytokine Res off J Int Soc Interf Cytokine Res 28:133\u2013139. https:\/\/doi.org\/10.1089\/jir.2007.0992","journal-title":"J Interf Cytokine Res off J Int Soc Interf Cytokine Res"},{"key":"9907_CR70","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1186\/s12885-015-1572-7","volume":"15","author":"AR Rowson-Hodel","year":"2015","unstructured":"Rowson-Hodel AR, Manjarin R, Trott JF et al (2015) Neoplastic transformation of porcine mammary epithelial cells in vitro and tumor formation in vivo. BMC Cancer 15:562. https:\/\/doi.org\/10.1186\/s12885-015-1572-7","journal-title":"BMC Cancer"},{"key":"9907_CR71","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1038\/oncsis.2016.19","volume":"5","author":"A Saalfrank","year":"2016","unstructured":"Saalfrank A, Janssen K-P, Ravon M et al (2016) A porcine model of osteosarcoma. Oncogenesis 5:e210\u2013e210. https:\/\/doi.org\/10.1038\/oncsis.2016.19","journal-title":"Oncogenesis"},{"key":"9907_CR72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.stem.2016.06.003","volume":"19","author":"K Sato","year":"2016","unstructured":"Sato K, Oiwa R, Kumita W et al (2016) Generation of a nonhuman primate model of severe combined immunodeficiency using highly efficient genome editing. Cell Stem Cell 19:127\u2013138. https:\/\/doi.org\/10.1016\/j.stem.2016.06.003","journal-title":"Cell Stem Cell"},{"key":"9907_CR73","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1038\/s41598-017-02912-9","volume":"7","author":"KM Schachtschneider","year":"2017","unstructured":"Schachtschneider KM, Liu Y, M\u00e4kel\u00e4inen S et al (2017a) Oncopig soft-tissue sarcomas recapitulate key transcriptional features of human sarcomas. Sci Rep 7:2624. https:\/\/doi.org\/10.1038\/s41598-017-02912-9","journal-title":"Sci Rep"},{"key":"9907_CR74","doi-asserted-by":"publisher","unstructured":"Schachtschneider KM, Schwind RM, Darfour-Oduro KA, et al (2017b) A validated, transitional and translational porcine model of hepatocellular carcinoma. Oncotarget 8:63620\u201363634. https:\/\/doi.org\/10.18632\/oncotarget.18872","DOI":"10.18632\/oncotarget.18872"},{"key":"9907_CR75","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3389\/fonc.2019.00209","volume":"9","author":"M Schenk","year":"2019","unstructured":"Schenk M, Matar AJ, Hanekamp I et al (2019) Development of a transplantable GFP+ B-Cell lymphoma tumor cell line from MHC-Defined miniature swine: potential for a large animal tumor model. Front Oncol 9:209","journal-title":"Front Oncol"},{"key":"9907_CR76","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-animal-022114-110815","volume":"3","author":"LB Schook","year":"2015","unstructured":"Schook LB, Collares TV, Darfour-Oduro KA et al (2015a) Unraveling the swine genome: implications for human health. Annu Rev Anim Biosci 3:219\u2013244. https:\/\/doi.org\/10.1146\/annurev-animal-022114-110815","journal-title":"Annu Rev Anim Biosci"},{"key":"9907_CR77","doi-asserted-by":"publisher","first-page":"e0128864","DOI":"10.1371\/journal.pone.0128864","volume":"10","author":"LB Schook","year":"2015","unstructured":"Schook LB, Collares TV, Hu W et al (2015b) A genetic porcine model of cancer. PLoS One 10:e0128864. https:\/\/doi.org\/10.1371\/journal.pone.0128864","journal-title":"PLoS One"},{"key":"9907_CR78","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jneumeth.2013.10.002","volume":"221","author":"L Selek","year":"2014","unstructured":"Selek L, Seigneuret E, Nugue G et al (2014) Imaging and histological characterization of a human brain xenograft in pig: the first induced glioma model in a large animal. J Neurosci Methods 221:159\u2013165. https:\/\/doi.org\/10.1016\/j.jneumeth.2013.10.002","journal-title":"J Neurosci Methods"},{"key":"9907_CR79","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1172\/JCI75447","volume":"124","author":"JC Sieren","year":"2014","unstructured":"Sieren JC, Meyerholz DK, Wang X-J et al (2014) Development and translational imaging of a TP53 porcine tumorigenesis model. J Clin Invest 124:4052\u20134066. https:\/\/doi.org\/10.1172\/JCI75447","journal-title":"J Clin Invest"},{"key":"9907_CR80","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1158\/1078-0432.CCR-18-1512","volume":"25","author":"J Strauss","year":"2019","unstructured":"Strauss J, Heery CR, Kim JW et al (2019) First-in-human phase I trial of a tumor-targeted cytokine (NHS-IL12) in subjects with metastatic solid tumors. Clin Cancer Res an off J Am Assoc Cancer Res 25:99\u2013109. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1512","journal-title":"Clin Cancer Res an off J Am Assoc Cancer Res"},{"key":"9907_CR81","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.vetimm.2016.06.011","volume":"178","author":"S Suzuki","year":"2016","unstructured":"Suzuki S, Iwamoto M, Hashimoto M et al (2016) Generation and characterization of RAG2 knockout pigs as animal model for severe combined immunodeficiency. Vet Immunol Immunopathol 178:37\u201349. https:\/\/doi.org\/10.1016\/j.vetimm.2016.06.011","journal-title":"Vet Immunol Immunopathol"},{"key":"9907_CR82","doi-asserted-by":"publisher","unstructured":"Suzuki S, Iwamoto M, Saito Y, et al (2012) Il2rg gene-targeted severe combined immunodeficiency pigs. Cell Stem Cell 10:753\u2013758. https:\/\/doi.org\/10.1016\/j.stem.2012.04.021","DOI":"10.1016\/j.stem.2012.04.021"},{"key":"9907_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2020.06.031","author":"HL Tan","year":"2020","unstructured":"Tan HL, Kim G, Charles CJ et al (2020) Safety, pharmacokinetics and tissue penetration of PIPAC paclitaxel in a swine model. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. https:\/\/doi.org\/10.1016\/j.ejso.2020.06.031","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"9907_CR84","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/TACG.S18693","volume":"5","author":"D Tasher","year":"2012","unstructured":"Tasher D, Dalal I (2012) The genetic basis of severe combined immunodeficiency and its variants. Appl Clin Genet 5:67\u201380. https:\/\/doi.org\/10.2147\/TACG.S18693","journal-title":"Appl Clin Genet"},{"key":"9907_CR85","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1038\/s41598-020-62167-9","volume":"10","author":"MS Tora","year":"2020","unstructured":"Tora MS, Texakalidis P, Neill S et al (2020) Lentiviral vector induced modeling of high-grade spinal cord glioma in minipigs. Sci Rep 10:5291. https:\/\/doi.org\/10.1038\/s41598-020-62167-9","journal-title":"Sci Rep"},{"key":"9907_CR86","doi-asserted-by":"publisher","unstructured":"Van Norman GA (2019) Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach? JACC Basic to Transl Sci 4:845\u2013854. https:\/\/doi.org\/10.1016\/j.jacbts.2019.10.008","DOI":"10.1016\/j.jacbts.2019.10.008"},{"key":"9907_CR87","first-page":"15","volume":"8","author":"I Velikyan","year":"2018","unstructured":"Velikyan I, Lindhe \u00d6 (2018) Preparation and evaluation of a (68)Ga-labeled RGD-containing octapeptide for noninvasive imaging of angiogenesis: biodistribution in non-human primate. Am J Nucl Med Mol Imaging 8:15\u201331","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"9907_CR88","doi-asserted-by":"publisher","unstructured":"Vozenin M-C, De Fornel P, Petersson K, et al (2019) The advantage of FLASH radiotherapy confirmed in mini-pig and cat-cancer patients. Clin Cancer Res 25:35\u201342. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3375","DOI":"10.1158\/1078-0432.CCR-17-3375"},{"key":"9907_CR89","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.4049\/jimmunol.1501132","volume":"195","author":"EH Waide","year":"2015","unstructured":"Waide EH, Dekkers JCM, Ross JW et al (2015) Not all SCID pigs are created equally: two independent mutations in the artemis gene cause SCID in pigs. J Immunol 195:3171\u20133179. https:\/\/doi.org\/10.4049\/jimmunol.1501132","journal-title":"J Immunol"},{"key":"9907_CR90","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","volume":"20","author":"CH Wong","year":"2019","unstructured":"Wong CH, Siah KW, Lo AW (2019) Estimation of clinical trial success rates and related parameters. Biostatistics 20:273\u2013286. https:\/\/doi.org\/10.1093\/biostatistics\/kxx069","journal-title":"Biostatistics"},{"key":"9907_CR91","first-page":"4568","volume":"10","author":"L Yin","year":"2020","unstructured":"Yin L, Wang X-J, Chen D-X et al (2020) Humanized mouse model: a review on preclinical applications for cancer immunotherapy. Am J Cancer Res 10:4568\u20134584","journal-title":"Am J Cancer Res"}],"container-title":["Mammalian Genome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-021-09907-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00335-021-09907-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00335-021-09907-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T03:04:00Z","timestamp":1646967840000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00335-021-09907-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["9907"],"URL":"https:\/\/doi.org\/10.1007\/s00335-021-09907-y","relation":{},"ISSN":["0938-8990","1432-1777"],"issn-type":[{"value":"0938-8990","type":"print"},{"value":"1432-1777","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,2]]},"assertion":[{"value":"21 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"KS receives research funding from Guerbet United States LLC, NeoTherma Oncology, and Janssen Research Development LLC. KS is a scientific consultant for Sus Clinicals, Inc. LBS receives research funding from Guerbet United States LLC, and NeoTherma Oncology. LBS is CSO for Sus Clinicals, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}